The biotech industry is driven by purpose, and next month, we’ll be joining thousands of others in the industry at BIO 2026 to discuss solutions to impossible problems, avenues to achieve better outcomes, and our ‘why’.
Join Johnson & Johnson for R&D in the age of AI — a forum on innovation, strategy, and collaboration. Hear directly from leaders, engage in Q&A, and network with industry peers. Registration is open. Don’t miss it. https://t.co/mqoVV2y8KT
Are you working on the next wave of innovation in autoimmune disease? Join us for an event focused on moving beyond inflammation control to enable deep healing. Register here: https://t.co/3u358Wm8KB
Let's move beyond inflammation control to enable deep healing: restoring tissue structure, barrier integrity and homeostatic set points for durable patient outcomes. https://t.co/3u358Wm8KB
Are you an innovator in autoimmune disease? Join J&J to explore innovations moving beyond remission, as well as collaboration opportunities to bring these to patients. Register now to join on 16 June in Brussels or virtually: https://t.co/zPuotvmpXf
Today is the day! Apply for your chance to showcase your science to J&J leadership.
Submit your big ideas aimed at changing the trajectory of neurodegenerative diseases: https://t.co/G7BoezKpq5
Last call to apply!
It’s the final day to submit your novel strategies or approaches that aim to prevent or limit the progression of neurodegenerative diseases.
Apply today: https://t.co/2gn8hLJ0vh
Congratulations to the Unlocking Urologic Oncology Innovation QuickFire Challenge awardees!
Your bold innovations have the potential to reshape the future of urologic cancer treatments.
Join us in congratulating the awardees of the Unlocking Urologic Oncology Innovation QuickFire Challenge!
These innovators will receive award funding, mentorship & more to help improve treatment & care of patients with bladder & prostate cancers. https://t.co/Uy4sK1gOZY
From following the data to combining scientific fields, JLABS resident and CEO of Endura Therapeutics Adrian Sanborn is giving us his top 5 insights on the next frontier of drug discovery. Read the full blog here: https://t.co/1SMjfFOsZS
What’s happening across our JLABS? Subscribe to our Innovation newsletter to learn more about the incredible things our residents and members are doing, some upcoming opportunities, and what innovation looks like around the world: https://t.co/rKNoSPE1xC
Despite the rising popularity of AI-driven discoveries, there is no replacing the fundamentals of innovation and drug discovery in science. Read more in our latest blog: https://t.co/XlKrwpmDZ9
In our latest blog, Prabhu Velusami, Senior Director for Search and Evaluation EMEA, outlines 5 questions he believes all startups should ask when choosing their lead clinical indication. Read more: https://t.co/UdmKuaQi9q
CEO and co-founder of JLABS resident company Endura Therapeutics, a company developing small-molecule medicines that target disease-causing proteins, is sharing 5 insights on what he believes is the next frontier of drug discovery. Read more here: https://t.co/1SMjfFOsZS
Bringing together researchers, clinicians, advocates, & women living with Alzheimer’s to listen to panel discussions & participate in conversations on the impact of advances in neuroscience was an incredible way to celebrate International Women's Day. https://t.co/CMXeyfDVaF
From strong collaborations to capital efficiency, and everything in-between: these are the 5 insights that are changing innovation in healthcare today: https://t.co/XlKrwpmDZ9
Help transform the future of neurodegenerative disease research! Apply for the chance to pitch J&J leadership in London this July.
Deadline to submit: May 18 https://t.co/G7BoezKpq5
Calling all innovators! We’re looking for novel strategies or approaches that aim to prevent or limit the progression of neurodegenerative diseases.
Apply today: https://t.co/2gn8hLJ0vh
2 out of every 3 people living with Alzheimer’s disease are women. Last month, we hosted an event centered around the contributions made in Alzheimer’s research so far, and what the future of care looks like. Learn more here: https://t.co/CMXeyfDVaF